Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Dynamics of cell-free DNA in predicting response in adult diffuse glioma on chemoradiotherapy.

Cancer genetics - 1 Nov 2022

Husain Adil, Mishra Sridhar, Hadi Rahat, Sahu Avnish, Kumari Swati, Rastogi Madhup, Khurana Rohini, Shukla Saumya, Siddiqui Mohammed Haris, Husain Nuzhat

Abstract excerpt

BACKGROUND: Adult diffuse glioma (ADG) is a heterogeneous primary brain tumor with a variable prognosis and treatment response. Tissue biomarkers and molecular genetic profiling form an integral part of diagnosis and prognostication. However, obtaining tissue in inoperable locations and diagnosis of recurrence can be an issue. Cell-free DNA (cfDNA) may help to meet these challenges in the management of ADG....

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Biomarkers, Tumor
Share to Cell-Free Nucleic Acids

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Chemoradiotherapy

Share to DNA, Neoplasm

Share to Glioma

Share to High-Throughput Nucleotide Sequencing

Share to Mutation

Source

Identifiers

PMID: 36166960
DOI: 10.1016/j.cancergen.2022.09.006

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Dynamics of cell-free DNA in predicting response in adult diffuse glioma on chemoradiotherapy.PMID 36166960Read ↗

Molecular Diagnosis of Diffuse Gliomas through Sequencing of Cell-Free Circulating Tumor DNA from Cerebrospinal Fluid.Semantic proximity Read ↗

A Custom DNA-Based NGS Panel for the Molecular Characterization of Patients With Diffuse Gliomas: Diagnostic and Therapeutic ApplicationsSemantic proximity Read ↗

High prevalence of clonal hematopoiesis-type genomic abnormalities in cell-free DNA in invasive gliomas after treatment.Semantic proximity Read ↗

Clinical utility of plasma cell-free DNA (cfDNA) in diffuse gliomas for the detection of IDH1 R132H mutation.Semantic proximity Read ↗

Longitudinal analysis of diffuse glioma reveals cell state dynamics at recurrence associated with changes in genetics and the microenvironmentSemantic proximity Read ↗

CSF ctDNA analysis guides molecular reclassification of diffuse glioma patients.Semantic proximity Read ↗

Clinical Utility of Plasma Cell-Free DNA in Adult Patients with Newly Diagnosed Glioblastoma: A Pilot Prospective Study.Semantic proximity Read ↗

Application of Circulating Tumor DNA in the Auxiliary Diagnosis and Prognosis Prediction of GliomaSemantic proximity Read ↗

Characterizing the Genomic Landscape of Brain Glioma With Circulating Tumor DNA From Tumor In Situ FluidSemantic proximity Read ↗

Detection of gene mutations and gene-gene fusions in circulating cell-free DNA of glioblastoma patients: an avenue for clinically relevant diagnostic analysis.Semantic proximity Read ↗

IDH1 mutation is detectable in plasma cell-free DNA and is associated with survival outcome in glioma patients.Semantic proximity Read ↗

Longitudinal molecular trajectories of diffuse glioma in adults.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.